These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21902278)

  • 41. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping algorithms for molecular similarity analysis and ligand-based virtual screening: design of DynaMAD and comparison with MAD and DMC.
    Eckert H; Vogt I; Bajorath J
    J Chem Inf Model; 2006; 46(4):1623-34. PubMed ID: 16859294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple target screening method for robust and accurate in silico ligand screening.
    Fukunishi Y; Mikami Y; Kubota S; Nakamura H
    J Mol Graph Model; 2006 Sep; 25(1):61-70. PubMed ID: 16376595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Random reduction in fingerprint bit density improves compound recall in search calculations using complex reference molecules.
    Wang Y; Geppert H; Bajorath J
    Chem Biol Drug Des; 2008 Jun; 71(6):511-7. PubMed ID: 18466274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potency-directed similarity searching using support vector machines.
    Wassermann AM; Heikamp K; Bajorath J
    Chem Biol Drug Des; 2011 Jan; 77(1):30-8. PubMed ID: 21114788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The future of virtual compound screening.
    Heikamp K; Bajorath J
    Chem Biol Drug Des; 2013 Jan; 81(1):33-40. PubMed ID: 23253129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FieldScreen: virtual screening using molecular fields. Application to the DUD data set.
    Cheeseright TJ; Mackey MD; Melville JL; Vinter JG
    J Chem Inf Model; 2008 Nov; 48(11):2108-17. PubMed ID: 18991371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Grid heterogeneity in in-silico experiments: an exploration of drug screening using DOCK on cloud environments.
    Yim WW; Chien S; Kusumoto Y; Date S; Haga J
    Stud Health Technol Inform; 2010; 159():181-90. PubMed ID: 20543437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation.
    Geppert H; Vogt M; Bajorath J
    J Chem Inf Model; 2010 Feb; 50(2):205-16. PubMed ID: 20088575
    [No Abstract]   [Full Text] [Related]  

  • 53. How do 2D fingerprints detect structurally diverse active compounds? Revealing compound subset-specific fingerprint features through systematic selection.
    Heikamp K; Bajorath J
    J Chem Inf Model; 2011 Sep; 51(9):2254-65. PubMed ID: 21793563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VS-APPLE: A Virtual Screening Algorithm Using Promiscuous Protein-Ligand Complexes.
    Okuno T; Kato K; Terada TP; Sasai M; Chikenji G
    J Chem Inf Model; 2015 Jun; 55(6):1108-19. PubMed ID: 26057716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments.
    Ebalunode JO; Zheng W
    J Chem Inf Model; 2009 Jun; 49(6):1313-20. PubMed ID: 19480404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virtual screening of Abl inhibitors from large compound libraries by support vector machines.
    Liu XH; Ma XH; Tan CY; Jiang YY; Go ML; Low BC; Chen YZ
    J Chem Inf Model; 2009 Sep; 49(9):2101-10. PubMed ID: 19689138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.
    Bender A; Glen RC
    J Chem Inf Model; 2005; 45(5):1369-75. PubMed ID: 16180913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a fingerprint reduction approach for Bayesian similarity searching based on Kullback-Leibler divergence analysis.
    Nisius B; Vogt M; Bajorath J
    J Chem Inf Model; 2009 Jun; 49(6):1347-58. PubMed ID: 19480403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.